文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

终于,球囊有了用武之地:延长自动化血管内支持增强猪休克模型的闭环复苏

Finally, a use for balloons: Extended automated endovascular support enhances closed-loop resuscitation in a porcine model of shock.
PubMed 文献 · J Trauma Acute Care Surg · 2026-06-05
一句话结论猪缺血再灌注休克模型中,初始180分钟EPACC+PACC-MAN较单用PACC-MAN显著减少24小时去甲肾上腺素用量(210.77 mcg/kg vs 1102.0 mcg/kg,p=0.045),生理终点无显著差异。

该研究在12头猪中建立30%失血+45分钟完全性1区主动脉阻断诱导的缺血再灌注损伤和血管麻痹模型,复苏至等容量后随机分为EPACC+PACC-MAN组(180分钟动态部分主动脉球囊压力增强,根据动物生理自主调节)与单用PACC-MAN自动化重症管理组,均进行24小时重症监护。主要终点中,低血压时间百分比(3.10% vs 3.75%,p=0.47)、高血压时间百分比(8.90% vs 5.58%,p=0.13)及总晶体液量(198.3 mL/kg vs 308.2 mL/kg,P=0.38)均无显著差异;EPACC+PACC-MAN组研究期间去甲肾上腺素用量显著更少(210.77 mcg/kg vs 1102.0 mcg/kg,p=0.045)。作者认为,在初始复苏中以EPACC支持血流动力学以减轻严重血管麻痹,可在24小时研究中持续限制血管升压药需求而不损害生理终点;血管内装置的自动化可能在严重休克状态管理及增强自主复苏中起辅助作用,尤其在资源受限的医疗环境中。证据等级为Level IV。

要点

  • 猪缺血再灌注休克模型中,初始180分钟EPACC+PACC-MAN较单用PACC-MAN显著减少24小时去甲肾上腺素用量(210.77 mcg/kg vs 1102.0 mcg/kg,p=0.045)。
  • 两组低血压时间百分比无显著差异(EPACC+PACC-MAN 3.10% vs PACC-MAN 3.75%,p=0.47)。
  • 两组高血压时间百分比无显著差异(EPACC+PACC-MAN 8.90% vs PACC-MAN 5.58%,p=0.13)。
  • 两组总晶体液量无显著差异(EPACC+PACC-MAN 198.3 mL/kg vs PACC-MAN 308.2 mL/kg,P=0.38)。
  • 作者认为血管内装置自动化可能在严重休克管理及增强自主复苏中起辅助作用,尤其在资源受限的医疗环境中。

适用人群与场景

  • 12头猪,经历30%失血后45分钟完全性1区主动脉阻断,诱导缺血再灌注损伤和血管麻痹,随后输血至等容量。

诊断标准与关键阈值

  • 低血压定义为平均动脉压<60 mm Hg,高血压定义为平均动脉压>70 mm Hg。

处置流程与药物剂量

  • EPACC+PACC-MAN组接受180分钟动态部分主动脉球囊压力增强,根据动物生理自主调节,联合自动化液体和药物输送系统PACC-MAN。
  • PACC-MAN组仅接受自动化重症管理。
  • 两组均进行24小时重症监护。

研究设计与关键结果

  • 研究类型为猪缺血再灌注损伤模型的随机对照实验,样本量12头猪。
  • 主要终点:低血压时间百分比EPACC+PACC-MAN 3.10% vs PACC-MAN 3.75%(p=0.47),无显著差异;高血压时间百分比8.90% vs 5.58%(p=0.13),无显著差异;总晶体液量198.3 mL/kg vs 308.2 mL/kg(P=0.38),无显著差异。
  • 去甲肾上腺素用量EPACC+PACC-MAN 210.77 mcg/kg vs PACC-MAN 1102.0 mcg/kg(p=0.045),EPACC+PACC-MAN组显著更少。
  • 次要终点包括乳酸负荷、肌酐、尿量、生物标志物和组织病理学,摘要未报告具体结果。

证据类型、等级与局限

  • 证据类型:动物实验(猪模型),证据等级Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在初始复苏中以EPACC支持血流动力学以减轻严重血管麻痹,可在此24小时研究中持续限制血管升压药需求而不损害生理终点。
  • 作者认为,血管内装置的自动化可能在严重休克状态管理及增强自主复苏中起辅助作用,尤其在资源受限的医疗环境中。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Endovascular Perfusion Augmentation for Critical Care (EPACC) is a method of dynamic aortic balloon catheter titration for precision hemodynamic support. EPACC has the potential to augment hemodynamics in conjunction with conventional resuscitation strategies. We previously described how even short periods of EPACC, along with an automated fluid and drug delivery system termed Precision Automated Critical Care Management (PACC-MAN) can reduce resuscitation requirements over the first few hours after severe ischemia-reperfusion injury (IRI). We sought to understand if an initial 180 minutes of EPACC+PACC-MAN can offset vasopressor requirements over 24 hours of critical care compared with PACC-MAN alone in an established IRI model.

METHODS: Twelve swine underwent 30% hemorrhage, then 45 minutes of complete zone 1 aortic occlusion, inducing IRI and vasoplegia. Animals were then transfused to euvolemia and randomized to EPACC+PACC-MAN (180 min of dynamic partial aortic balloon pressure augmentation that autonomously adjusted based on the animal's physiology) or PACC-MAN automated critical care alone. Critical care lasted for 24 hours in both groups. Primary outcomes included duration of hypotension (mean arterial pressure <60 mm Hg), hypertension (mean arterial pressure >70 mm Hg), total crystalloid, and norepinephrine volumes. Secondary outcomes included lactate load, creatinine, urine output, biomarkers, and histopathology.

RESULTS: Percent time spent in hypotension for EPACC+PACC-MAN versus PACC-MAN (3.10% vs. 3.75%, p=0.47) and hypertension (8.90% vs 5.58%, p=0.13) was not significantly different. Total crystalloid volume for EPACC+PACC-MAN versus PACC-MAN was not significant (198.3 mL/kg vs. 308.2 mL/kg, P=0.38). EPACC+PACC-MAN required significantly less norepinephrine during the study period (210.77 mcg/kg vs. 1102.0 mcg/kg, p=0.045).

CONCLUSION: Supporting hemodynamics with EPACC to mitigate severe vasoplegia of initial resuscitation has a sustained effect on limiting vasopressor requirements in this 24-hour study, without compromising physiologic endpoints. Automation of endovascular devices may play an adjunctive role in managing severe shock states and augmenting autonomous resuscitation, particularly in resource-constrained care environments. (J Trauma Acute Care Surg 2026;00:000-000. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).

LEVEL OF EVIDENCE: Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Wood EC, Gomez MK, Lane MR, et al. Finally, a use for balloons: Extended automated endovascular support enhances closed-loop resuscitation in a porcine model of shock. J Trauma Acute Care Surg. 2026. PMID: 42246954. doi:10.1097/TA.0000000000005039

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。